Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2016

May 20, 2016

34129_dirs_2016-05-20_5846e1cd-a69a-4718-b9a7-3fc575ddcdb1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-05-18

Reporting Person: Costa Paulo F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-18 Stock Option (right to buy) $21.06 A 8500 Acquired 2026-05-18 Common Stock (8500) Direct
2016-05-18 Stock Option (right to buy) $21.06 A 5674 Acquired 2026-05-18 Common Stock (5674) Direct

Footnotes

F1: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.

F2: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.